The changing paradigm of tumour response to irradiation.

Tumours contain multiple different cell populations, including cells derived from the bone marrow as well as cancer-associated fibroblasts and various stromal populations including the vasculature. The microenvironment of the tumour cells plays a significant role in the response of the tumour to radiation treatment. Low levels of oxygen (hypoxia) caused by the poorly organized vasculature in tumours have long been known to affect radiation response; however, other aspects of the microenvironment may also play important roles. This article reviews some of the old literature concerning tumour response to irradiation and relates this to current concepts about the role of the tumour microenvironment in tumour response to radiation treatment. Included in the discussion are the role of cancer stem cells, radiation damage to the vasculature and the potential for radiation to enhance immune activity against tumour cells. Radiation treatment can cause a significant influx of bone marrow-derived cell populations into both normal tissues and tumours. Potential roles of such cells may include enhancing vascular recovery as well as modulating immune reactivity.

[1]  M. Tsao,et al.  Cetuximab Inhibits T790M-Mediated Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Lung Adenocarcinoma Patient-Derived Xenograft Mouse Model. , 2016, Clinical lung cancer.

[2]  K. E. Visser,et al.  Neutrophils in cancer: neutral no more , 2016, Nature Reviews Cancer.

[3]  Ping Wang,et al.  Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy. , 2016, Cancer letters.

[4]  E. Schröck,et al.  An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells. , 2016, Cancer research.

[5]  P. Tamayo,et al.  A genetic basis for the variation in the vulnerability of cancer to DNA damage , 2016, Nature Communications.

[6]  F. Pajonk,et al.  Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status. , 2016, International journal of radiation oncology, biology, physics.

[7]  Mechthild Krause,et al.  Radiation oncology in the era of precision medicine , 2016, Nature Reviews Cancer.

[8]  A. Naghavi,et al.  Clinical trials exploring the benefit of immunotherapy and radiation in cancer treatment: A review of the past and a look into the future. , 2016, Current problems in cancer.

[9]  S. Demaria,et al.  Role of Local Radiation Therapy in Cancer Immunotherapy. , 2015, JAMA oncology.

[10]  Nawaid Usmani,et al.  The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention. , 2015, Seminars in radiation oncology.

[11]  R. Bristow,et al.  Hypoxia and Predicting Radiation Response. , 2015, Seminars in radiation oncology.

[12]  C. Drake,et al.  Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy. , 2015, The Lancet. Oncology.

[13]  Drew J. Adams,et al.  Radiotherapy in the Era of Precision Medicine. , 2015, Seminars in radiation oncology.

[14]  George Yancey Gillespie,et al.  Patient-Derived Xenografts as a Model System for Radiation Research. , 2015, Seminars in radiation oncology.

[15]  Michael D. Brooks,et al.  Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer. , 2015, Cell stem cell.

[16]  Robert J. Griffin,et al.  Indirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery. , 2015, International journal of radiation oncology, biology, physics.

[17]  R. Dacosta,et al.  Emerging Applications for Optically Enabled Intravital Microscopic Imaging in Radiobiology , 2015, Molecular imaging.

[18]  Zachary C. Dobbin,et al.  Ovarian and cervical cancer patient derived xenografts: The past, present, and future. , 2015, Gynecologic oncology.

[19]  Kevin J. Harrington,et al.  The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence , 2015, Nature Reviews Cancer.

[20]  N. Cordes,et al.  Focal adhesion signaling and therapy resistance in cancer. , 2015, Seminars in cancer biology.

[21]  F. Pajonk,et al.  Cancer stem cells, cancer cell plasticity and radiation therapy. , 2015, Seminars in cancer biology.

[22]  Yidong Yang,et al.  Systematic calibration of an integrated x-ray and optical tomography system for preclinical radiation research. , 2015, Medical physics.

[23]  S. C. Chafe,et al.  Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production. , 2015, Cancer research.

[24]  K. D. Castle,et al.  Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy , 2015, Science Translational Medicine.

[25]  I. Tannock,et al.  The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts , 2015, BMC Cancer.

[26]  Mina J. Bissell,et al.  Identification of genetic loci that control mammary tumor susceptibility through the host microenvironment , 2015, Scientific Reports.

[27]  D. Hedley,et al.  The clinical significance of hypoxia in human cancers. , 2015, Seminars in nuclear medicine.

[28]  J. Visvader,et al.  Patient-derived xenograft models of breast cancer and their predictive power , 2015, Breast Cancer Research.

[29]  Sabine Tejpar,et al.  IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies , 2015, Science Translational Medicine.

[30]  H. Kohrt,et al.  Current clinical trials testing combinations of immunotherapy and radiation. , 2015, Seminars in radiation oncology.

[31]  S. Siva,et al.  Abscopal effects of radiation therapy: a clinical review for the radiobiologist. , 2015, Cancer letters.

[32]  Andre Dekker,et al.  Radiogenomics: the search for genetic predictors of radiotherapy response. , 2014, Future oncology.

[33]  Wolfgang Enghardt,et al.  Pre-clinical research in small animals using radiotherapy technology--a bidirectional translational approach. , 2014, Zeitschrift fur medizinische Physik.

[34]  Igor Jurisica,et al.  Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study. , 2014, The Lancet. Oncology.

[35]  C. N. Coleman,et al.  Enhancing the efficacy of radiation therapy: premises, promises, and practicality. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  G. Zadeh,et al.  VEGF regulates region-specific localization of perivascular bone marrow-derived cells in glioblastoma. , 2014, Cancer research.

[37]  Ben Tran,et al.  Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. , 2014, Journal of the National Cancer Institute.

[38]  R. Hill,et al.  Hypoxia as a biomarker for radioresistant cancer stem cells , 2014, International journal of radiation biology.

[39]  R. Timmerman,et al.  Clinical Investigation : Thoracic Cancer No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy for Early-Stage Peripheral Non-Small Cell Lung Cancer : An Analysis of RTOG 0236 , 2022 .

[40]  A. Berlin,et al.  An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy. , 2014, The British journal of radiology.

[41]  D. Tang,et al.  Cancer stem cells and radioresistance , 2014, International journal of radiation biology.

[42]  David J Brenner,et al.  The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? , 2014, International journal of radiation oncology, biology, physics.

[43]  J. Brown,et al.  Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy. , 2014, The British journal of radiology.

[44]  Manuel Hidalgo,et al.  Patient-derived xenograft models: an emerging platform for translational cancer research. , 2014, Cancer discovery.

[45]  R. Bristow,et al.  Intratumoral hypoxia as the genesis of genetic instability and clinical prognosis in prostate cancer. , 2014, Advances in experimental medicine and biology.

[46]  P. Iyengar,et al.  Stereotactic Ablative Radiotherapy (SABR) for Non–Small Cell Lung Cancer , 2013, Seminars in Respiratory and Critical Care Medicine.

[47]  M. Busslinger,et al.  GATA-3 REGULATES THE SELF-RENEWAL OF LONG-TERM HEMATOPOIETIC STEM CELLS , 2013, Nature Immunology.

[48]  K. Prise,et al.  What is the Role of the Bystander Response in Radionuclide Therapies? , 2013, Front. Oncol..

[49]  S. Demaria,et al.  Radiotherapy Effects on Anti-Tumor Immunity: Implications for Cancer Treatment , 2013, Front. Oncol..

[50]  S. Demaria,et al.  Combining radiotherapy and cancer immunotherapy: a paradigm shift. , 2013, Journal of the National Cancer Institute.

[51]  C. Koch,et al.  Mechanisms of blood flow and hypoxia production in rat 9L-epigastric tumors. , 2012, Tumor microenvironment and therapy.

[52]  Søren M Bentzen,et al.  Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news? , 2011, International journal of radiation oncology, biology, physics.

[53]  Carl Virtanen,et al.  In Vivo Optical Imaging of Tumor and Microvascular Response to Ionizing Radiation , 2012, PloS one.

[54]  F. Pajonk,et al.  Radiation‐Induced Reprogramming of Breast Cancer Cells , 2012, Stem cells.

[55]  Jeong-Won Lee,et al.  Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma. , 2012, Anticancer research.

[56]  S. Halford,et al.  Phase I Clinical and Pharmacokinetic Evaluation of the Vascular-Disrupting Agent OXi4503 in Patients with Advanced Solid Tumors , 2012, Clinical Cancer Research.

[57]  M. M. Elkind,et al.  Radiation Response of Mammalian Cells Grown in Culture I. Repair of X-Ray Damage in Surviving Chinese Hamster Cells , 2012, Radiation research.

[58]  B. S. Sørensen,et al.  Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[59]  D. Kirsch Using Genetically Engineered Mice for Radiation Research , 2011, Radiation research.

[60]  M. Wicha,et al.  Ablation of breast cancer stem cells with radiation. , 2011, Translational oncology.

[61]  Erik Tryggestad,et al.  Small animal radiotherapy research platforms , 2011, Physics in medicine and biology.

[62]  P. Sykes,et al.  Radiation-Induced Bystander Effects: What Are They, and How Relevant Are They to Human Radiation Exposures? , 2011, Radiation research.

[63]  W. Wilson,et al.  Targeting hypoxia in cancer therapy , 2011, Nature Reviews Cancer.

[64]  D A Jaffray,et al.  Characterization of image quality and image-guidance performance of a preclinical microirradiator. , 2011, Medical physics.

[65]  Mechthild Krause,et al.  CD44: A Cancer Stem Cell–Related Biomarker with Predictive Potential for Radiotherapy , 2010, Clinical Cancer Research.

[66]  G. Wilson,et al.  The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity. , 2010, International journal of radiation oncology, biology, physics.

[67]  W. McBride,et al.  Radiation Resistance of Cancer Stem Cells: The 4 R's of Radiobiology Revisited , 2010, Stem cells.

[68]  H. Vogel,et al.  Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. , 2010, The Journal of clinical investigation.

[69]  Philippe Lambin,et al.  The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. , 2010, The Journal of clinical investigation.

[70]  R. McLendon,et al.  The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype , 2009, Cell cycle.

[71]  S. Hehlgans,et al.  Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[72]  Hui Wang,et al.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.

[73]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[74]  A. Krešo,et al.  Cancer stem cells in solid tumors: an overview. , 2009, Seminars in radiation oncology.

[75]  D. Chaplin,et al.  A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P) , 2009, Expert opinion on investigational drugs.

[76]  J. Erler,et al.  Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.

[77]  B. Wouters,et al.  Hypoxia signalling through mTOR and the unfolded protein response in cancer , 2008, Nature Reviews Cancer.

[78]  E. Rofstad,et al.  Temporal heterogeneity in blood supply in human tumor xenografts. , 2008, Neoplasia.

[79]  M. Krause,et al.  Exploring the role of cancer stem cells in radioresistance , 2008, Nature Reviews Cancer.

[80]  Richard P. Hill,et al.  Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability , 2008, Nature Reviews Cancer.

[81]  D. Wion,et al.  Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. , 2007, Cancer letters.

[82]  Jens Overgaard,et al.  Hypoxic radiosensitization: adored and ignored. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  M. Krause,et al.  Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[84]  G. Maki,et al.  Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia. , 2007, International journal of radiation oncology, biology, physics.

[85]  Frank Pajonk,et al.  The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. , 2006, Journal of the National Cancer Institute.

[86]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[87]  Irving L Weissman,et al.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.

[88]  R. Fisher,et al.  Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[89]  R. Sutherland Radiation-enhanced immune response to cancer: workshop, Anaheim, CA, April 17, 2005. , 2006, International journal of radiation oncology, biology, physics.

[90]  Chryso Kanthou,et al.  Disrupting tumour blood vessels , 2005, Nature Reviews Cancer.

[91]  N. Cordes,et al.  Integrin Signalling and the Cellular Response to Ionizing Radiation , 2003, Journal of Molecular Histology.

[92]  J. Fowler,et al.  Loss of biological effect in prolonged fraction delivery. , 2004, International journal of radiation oncology, biology, physics.

[93]  M. Horsman,et al.  Targeting the tumor vasculature: a strategy to improve radiation therapy , 2004, Expert review of anticancer therapy.

[94]  Jian Z. Wang,et al.  Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT). , 2003, International journal of radiation oncology, biology, physics.

[95]  Z. Fuks,et al.  Radiation and ceramide-induced apoptosis , 2003, Oncogene.

[96]  Mikael Karlsson,et al.  The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimisation problem. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[97]  N. Iscove,et al.  Hematopoietic stem cells engraft in mice with absolute efficiency , 2003, Nature Immunology.

[98]  Zvi Fuks,et al.  Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis , 2003, Science.

[99]  C. Koch,et al.  The Km for Radiosensitization of Human Tumor Cells by Oxygen is Much Greater than 3 mmHg and is Further Increased by Elevated Levels of Cysteine , 2001, Radiation research.

[100]  P Lambin,et al.  Low-dose hypersensitivity: current status and possible mechanisms. , 2001, International journal of radiation oncology, biology, physics.

[101]  P. Vaupel,et al.  Treatment resistance of solid tumors: role of hypoxia and anemia. , 2001, Medical oncology.

[102]  B. Wouters,et al.  Apoptosis, p53, and tumor cell sensitivity to anticancer agents. , 1999, Cancer research.

[103]  A. Giaccia,et al.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. , 1998, Cancer research.

[104]  B. Wouters,et al.  Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. , 1997, Radiation research.

[105]  S. Evans,et al.  Cysteine concentrations in rodent tumors: Unexpectedly high values may cause therapy resistance , 1996, International journal of cancer.

[106]  M. Dewhirst,et al.  Microvascular studies on the origins of perfusion-limited hypoxia. , 1996, The British journal of cancer. Supplement.

[107]  J. Hendry,et al.  Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[108]  S. A. Roberts,et al.  Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. , 1993, British Journal of Cancer.

[109]  W Budach,et al.  Impact of stromal sensitivity on radiation response of tumors. , 1993, Journal of the National Cancer Institute.

[110]  J. Folkman,et al.  The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.

[111]  R. James,et al.  Lack of a relationship between colony-forming efficiency and surviving fraction at 2 Gy. , 1991, Radiation research.

[112]  T. Kwok,et al.  The influence of cell-cell contact on radiosensitivity of human squamous carcinoma cells. , 1991, Radiation research.

[113]  G. Steel The ESTRO Breur lecture. Cellular sensitivity to low dose-rate irradiation focuses the problem of tumour radioresistance. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[114]  Richard P. Hill,et al.  The Basic Science of Oncology , 1989 .

[115]  G. Steel Recovery kinetics deduced from continuous low dose-rate experiments. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[116]  L. Milas,et al.  The proportion of stem cells in murine tumors. , 1989, International journal of radiation oncology, biology, physics.

[117]  C. West,et al.  Evaluation of surviving fraction at 2 Gy as a potential prognostic factor for the radiotherapy of carcinoma of the cervix. , 1989, International journal of radiation biology.

[118]  R. Sutherland Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.

[119]  M. Dewhirst,et al.  Temporal effects of 5.0 Gy radiation in healing subcutaneous microvasculature of a dorsal flap window chamber. , 1987, Radiation research.

[120]  A. Horwich,et al.  The dose-rate effect in human tumour cells. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[121]  L. Peters,et al.  The tumor bed effect: dependence of tumor take, growth rate, and metastasis on the time interval between irradiation and tumor cell transplantation. , 1987, International journal of radiation oncology, biology, physics.

[122]  R. Hill Sensitizers and radiation dose fractionation: results and interpretations. , 1986, International journal of radiation oncology, biology, physics.

[123]  S B Curtis,et al.  Lethal and potentially lethal lesions induced by radiation--a unified repair model. , 1986, Radiation research.

[124]  T C Stephens,et al.  Dose-rate effects and the repair of radiation damage. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[125]  B. Fertil,et al.  Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. , 1985, International journal of radiation oncology, biology, physics.

[126]  G. Steel,et al.  The radioresponsiveness of human tumours and the initial slope of the cell survival curve. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[127]  Hewitt Hb Second point: animal tumor models and their relevance to human tumor immunology. , 1983 .

[128]  R. Hill Radiation-induced changes in the in vivo growth rate of KHT sarcoma cells: implications for the comparison of growth delay and cell survival. , 1980, Radiation research.

[129]  J. Hendry,et al.  The Approximation in the Formulation for Survival S = exp − (αD + βD2) , 1980 .

[130]  J. Hendry,et al.  The approximation in the formulation for survival S=exp-(alpha D + beta D2). , 1980, International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine.

[131]  L. Peters,et al.  Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma. , 1979, Journal of the National Cancer Institute.

[132]  H. Hewitt,et al.  A critical examination of the foundations of immunotherapy for cancer. , 1979, Clinical radiology.

[133]  B. Warren,et al.  The effect of intercellular contact on the radiation sensitivity of KHT sarcoma cells. , 1979, Radiation research.

[134]  G. Barendsen,et al.  The Proliferative Status And Clonogenic Capacity Of Tumour Cells In A Transplantable Rhabdomyosarcoma Of The Rat Before And After Irradiation With 800 Rad Of X‐Rays , 1978, Cell and tissue kinetics.

[135]  L. Milas Effects of C. parvum on radiation response of murine tumors. , 1977, Developments in biological standardization.

[136]  H. Suit,et al.  Radiation therapy and Corynebacterium parvum in the treatment of murine tumors , 1976, Cancer.

[137]  J F Fowler,et al.  The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation. , 1976, Radiation research.

[138]  G. Adams,et al.  Time-resolved oxygen effects in irradiated bacteria and mammalian cells: a rapid-mix study. , 1975, Radiation research.

[139]  J. Fowler,et al.  The effect of single and fractionated doses of x rays on the effective proportion of hypoxic cells in C 3 H mouse mammary tumours. , 1972, The British journal of radiology.

[140]  R. Sutherland,et al.  Effects of intercellular contact on repair of radiation damage. , 1972, Experimental cell research.

[141]  N. J. McNally,et al.  Recovery from sub-lethal damage by hypoxic tumour cells in vivo. , 1972, The British journal of radiology.

[142]  R. Hill,et al.  The effect of anaemia on the fraction of hypoxic cells in an experimental tumour. , 1971, The British journal of radiology.

[143]  H. Suit,et al.  Experimental evaluation of tumor bed effect for C3H mouse mammary carcinoma and for C3H mouse fibrosarcoma. , 1971, Radiation research.

[144]  L. V. van Putten,et al.  Oxygenation status of a transplantable tumor during fractionated radiation therapy. , 1968, Journal of the National Cancer Institute.

[145]  R. E. Ellis,et al.  The response of C3H mammary tumours to irradiation in single and fractionated doses. , 1968, The British journal of radiology.

[146]  W. K. Sinclair Cyclic x-ray responses in mammalian cells in vitro. , 1968, Radiation research.

[147]  R. Thomlinson,et al.  The gross response of an experimental tumour to single doses of x-rays. , 1967, British Journal of Cancer.

[148]  L. Tolmach,et al.  DEMONSTRATION OF AN ANOXIC COMPONENT IN A MOUSE TUMOR-CELL POPULATION BY IN VIVO ASSAY OF SURVIVAL FOLLOWING IRRADIATION. , 1964, Radiology.

[149]  H. Suit,et al.  RESPONSE OF SPONTANEOUS MAMMARY CARCINOMA OF THE C3H MOUSE TO X IRRADIATION GIVEN UNDER CONDITIONS OF LOCAL TISSUE ANOXIA. , 1963, Journal of the National Cancer Institute.

[150]  Gray Lh Radiobiologic basis of oxygen as a modifying factor in radiation therapy. , 1961 .

[151]  L. H. Gray Radiobiologic basis of oxygen as a modifying factor in radiation therapy. , 1961, The American journal of roentgenology, radium therapy, and nuclear medicine.

[152]  H. Sutton,et al.  Radiation response of mammalian cells grown in culture. 1. Repair of X-ray damage in surviving Chinese hamster cells. , 1960, Radiation research.